- Home
- THFF vs ARCT Comparison
THFF vs ARCT Comparison
Compare THFF & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | THFF | ARCT |
|---|---|---|
| Founded | 1984 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 796.4M | 189.9M |
| IPO Year | 1995 | 2019 |
Fundamental Metrics
Financial Performance| Metric | THFF | ARCT |
|---|---|---|
| Price | $61.91 | $6.61 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $62.00 | $28.33 |
| AVG Volume (30 Days) | 50.4K | ★ 431.4K |
| Earning Date | 05-05-2026 | 06-08-2026 |
| Dividend Yield | ★ 3.65% | N/A |
| EPS Growth | ★ 67.00 | 20.00 |
| EPS | ★ 6.68 | N/A |
| Revenue | N/A | ★ $82,031,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.55 | $93.19 |
| P/E Ratio | $9.20 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $42.05 | $5.85 |
| 52 Week High | $69.21 | $24.14 |
Technical Indicators
Market Signals| Indicator | THFF | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 42.07 | 36.54 |
| Support Level | $50.50 | $5.93 |
| Resistance Level | $63.04 | $7.88 |
| Average True Range (ATR) | 1.73 | 0.44 |
| MACD | -0.39 | -0.15 |
| Stochastic Oscillator | 29.27 | 6.74 |
Price Performance
Historical ComparisonAbout THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.